# Hospira, Inc., a Pfizer Company: Sufentanil Citrate Injection shortage update (limited availability from this maker)

**Score:** 60/100

| Field | Value |
|---|---|
| Manufacturer | Hospira, Inc., a Pfizer Company |
| Drug | Sufentanil Citrate Injection |
| Dosage form | Injection |
| Therapeutic category | Analgesia/Addiction, Pediatric |
| Status | Current |
| Stage | Shortage revised (availability or dates changed) |
| Availability | Limited availability |
| Reason | Other |
| Presentations affected | 1 |
| Package NDCs | 0409-3382-21 |
| Manufacturer supply note | Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay |
| First posted | 2022-05-03 |
| Updated | 2026-10-21 |

## Why this score
- Shortage details just changed.
- Limited availability.
- Sterile injectable: hospital and 503B demand.

Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list) (https://dps.fda.gov/drugshortages). Last refreshed: 2026-11-04T06:10:12.565Z.
From the openFDA drug shortages endpoint, which mirrors the FDA drug shortage list and can lag it by days. Availability and recovery notes are the manufacturer's own statements to FDA. Company and product level only. Verify with FDA and the manufacturer before acting.